Regeneron elects dr. craig b. thompson to board of directors

Former president and ceo of memorial sloan kettering cancer center brings a unique combination of business and scientific leadership, with exceptional experience in immuno-oncology, translational research and precision medicine tarrytown, n.y. , oct. 3, 2022 /prnewswire/ -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced that craig b.

REGN Ratings Summary

REGN Quant Ranking